Show simple item record

AuthorAbdulrhim, Sara
AuthorAwaisu, Ahmed
AuthorIbrahim, Mohamed Izham Mohamed
AuthorDiab, Mohammad Issam
AuthorHussain, Mohamed Abdelazim Mohamed
AuthorAl Raey, Hend
AuthorIsmail, Mohammed Thahir
AuthorSankaralingam, Sowndramalingam
Available date2022-12-15T07:16:23Z
Publication Date2022
Publication NameInternational Journal of Clinical Pharmacy
ResourceScopus
URIhttp://dx.doi.org/10.1007/s11096-021-01327-x
URIhttp://hdl.handle.net/10576/37311
AbstractBackground Diabetes mellitus is a complex multi-system disorder, requiring multi-disciplinary care. The conventional care model, where physicians are the sole caregivers may not be optimal. Addition of other healthcare team members improves healthcare outcomes for patients with diabetes. Aim To evaluate the impact of pharmacist-involved collaborative care on diabetes-related outcomes among patients with diabetes attending a primary healthcare setting in Qatar using real-world data. Method A retrospective cohort study was conducted among patients with diabetes attending Qatar Petroleum Diabetes Clinic. Patients were categorized as either receiving pharmacist-involved collaborative care (intervention group) or usual care (control group). Data were analyzed using SPSS®. Glycemic control (glycated hemoglobin A1c, HbA1c), blood pressure, lipid profile, and body mass index were evaluated at baseline and up to 17 months of follow-up. Results After 17 months of follow-up, pharmacist-involved collaborative care compared to usual care resulted in a significant decrease in HbA1c (6.8 ± 1.2% vs. 7.1 ± 1.3%, p < 0.01). Moreover, compared to baseline, pharmacist-involved collaborative care significantly improved (p < 0.05) the levels of HbA1c (7.5% vs. 6.8%), low-density lipoprotein cholesterol (3.7 mmol/L vs. 2.8 mmol/L), total cholesterol (5.43 mmol/L vs. 4.34 mmol/L), and body mass index (30.42 kg/m2 vs. 30.17 kg/m2) after 17 months within the intervention group. However, no significant changes for these parameters occurred within the control group. Conclusion The implementation of pharmacist-involved collaborative care in a primary healthcare setting improved several diabetes-related outcomes over 17 months. Future studies should determine the long-term impact of this care model.
SponsorThe authors acknowledge Qatar University for funding the research through the Office of Research Support grant numbers QUST-2-CPH-2019-1 and QUST-2-CPH-2018-12.
Languageen
PublisherSpringer Science and Business Media Deutschland GmbH
SubjectClinical outcomes
Collaborative care
Diabetes
Pharmacist-involved
Primary care
TitleImpact of pharmacist-involved collaborative care on diabetes management in a primary healthcare setting using real-world data
TypeArticle
Pagination153-162
Issue Number1
Volume Number44
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record